TITLE

Sex-Gender Differences in Diabetes Vascular Complications and Treatment

AUTHOR(S)
Franconi, Flavia; Campesi, Ilaria; Occhioni, Stefano; Tonolo, Giancarlo
PUB. DATE
June 2012
SOURCE
Endocrine, Metabolic & Immune Disorders - Drug Targets;Jun2012, Vol. 12 Issue 2, p179
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Diabetes mellitus and cardiovascular diseases act as two sides of the same coin: diabetes is an important risk factor for cardiovascular disease while patients with ischemic cardiovascular diseases often have diabetes or pre-diabetes. As firstly shown by Framingham study, diabetic women have an increased cardiovascular risk about 3.5 fold higher than non diabetic women, against an increase of 'only' 2.1 fold found in male subjects. In view of the impact of sexual hormones on glucose homeostasis, the molecular pathways involved in insulin resistance suggest a sex-gender specificity mechanism in the development of diabetic complications leading to the unmet need of sex-gender therapeutic approaches. This has also been seen in other diabetic complications such as renal diseases, which seems to progress at a faster rate in females compared with males and women benefit less from treatment than do men. Of note, none of the trials done so far are primarily designed to assess sex-gender differences in the benefit from a specific intervention strategy, de facto excluding fertile women from experimentation. In order to provide a more evidence based medicine for women and to reach equity between men and women, sex-gender epidemiological reports, preclinical and clinical research are mandatory to evaluate the impact of gender on the outcomes and to improve sex-gender awareness and competency in the health care system. Future studies should consider sex-gender differences in the setting of randomized controlled trials with drugs.
ACCESSION #
75179762

 

Related Articles

  • Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future. Qi Tang; Xueqin Li; Peipei Song; Lingzhong Xu // Drug Discoveries & Therapeutics;Dec2015, Vol. 9 Issue 6, p380 

    Diabetes mellitus (DM) appears to be increasing rapidly, threatening to reduce life expectancy for humans around the globe. The International Diabetes Federation (IDF) has estimated that there will be 642 million people living with the disease by 2040 and half as many again who will be not...

  • Sex differences in metabolic homeostasis, diabetes, and obesity. Mauvais-Jarvis, Franck // Biology of Sex Differences;9/3/2015, Vol. 6 Issue 1, p1 

    There are fundamental aspects of the control of metabolic homeostasis that are regulated differently in males and females. This sex asymmetry represents an evolutionary paradigm for females to resist the loss of energy stores. This perspective discusses the most fundamental sex differences in...

  • Enumerating β-Cells in Whole Human Islets: Sex Differences and Associations With Clinical Outcomes After Islet Transplantation. Marchese, Enza; Rodeghier, Caitlin; Monson, Rebecca S.; McCracken, Benjamin; Shi, Tingqi; Schrock, Wesley; Martellotto, Joan; Oberholzer, Jose; Danielson, Kirstie K. // Diabetes Care;Nov2015, Vol. 38 Issue 11, pe176 

    The article presents research which focused on the impact of human islets on the sex differences and associations of patients who underwent islet transplantation. Topics covered include the use of islet transplantation as an experimental treatment for people with type 1 diabetes. Also mentioned...

  • EFFECT OF YOGA EXERCISE ON METABOLIC AND HOMEOSTATIC PARAMETERS OF INSULIN RESISTANCE. Pastucha, D.; Filipcikova, R.; Cajka, V.; Horakova, D.; Radova, L.; Reich, P.; Sovova, E. // Acta Medica Martiniana;Mar2012, Vol. 12 Issue 1, p35 

    The aim of this study is to assess the effect of yoga exercise on the anthropometric parameters and metabolic parameters in individuals regularly exercising yoga as well as to assess the possible impact on cardiovascular risk prevention. The study sample composed of two groups: A (57 healthy...

  • Lipid-lowering Therapies, Glucose Control and Incident Diabetes: Evidence, Mechanisms and Clinical Implications. Zafrir, Barak; Jain, Mohit // Cardiovascular Drugs & Therapy;Aug2014, Vol. 28 Issue 4, p361 

    Lipid-lowering therapies constitute an essential part in the treatment and prevention of cardiovascular diseases and are consistently shown to reduce adverse cardiovascular outcomes in wide-scale populations. Recently, there is increased awareness of the possibility that lipid-lowering drugs may...

  • Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy. García-Compeán, Diego; González-González, José; Lavalle-González, Fernando; González-Moreno, Emmanuel; Villarreal-Pérez, Jesús; Maldonado-Garza, Héctor; García-Compeán, Diego; González-González, José Alberto; Lavalle-González, Fernando Javier; González-Moreno, Emmanuel Irineo; Villarreal-Pérez, Jesús Zacarías; Maldonado-Garza, Héctor J // Digestive Diseases & Sciences;Feb2016, Vol. 61 Issue 2, p371 

    Hereditary type 2 diabetes mellitus is a risk factor for chronic liver disease, and ~30 % of patients with liver cirrhosis develop diabetes. Diabetes mellitus has been associated with cirrhotic and non-cirrhotic hepatitis C virus liver infection, can aggravate the course the liver infection, and...

  • Surgical Treatment of Diabetes. Kuritzky, Louis // Infectious Disease Alert;Feb2013 Clinical Briefs in Primary Care, p3 

    The article discusses a study conducted by a team which included M. L. Vetter and published in an issue of "Diabetes Spectrum" showing a comparison of bariatric surgical procedures for diabetes remission.

  • Bariatric Surgery vs Intensive Medical Therapy for Diabetes. Kuritzky, Louis // Infectious Disease Alert;Oct2013 Clincal Briefs, p19 

    The article discusses research being done on the efficacy of bariatric surgery in obese patients with type 2 diabetes mellitus, which references a study by S. R. Kashyap and colleagues published in a 2013 issue of "Diabetes Care."

  • Extreme Insulin Resistance in a Patient with Diabetes Ketoacidosis and Acute Myocardial Infarction. Oo, Yin H.; Karam, Jocelyne G.; Resta, Christine A. // Case Reports in Endocrinology;2013, p1 

    Hyperglycemia is common in hospitalized patients and associated with adverse clinical outcomes. In hospitalized patients, multiple factors contribute to hyperglycemia, such as underlying medical conditions, pathophysiological stress, and medications. The development of transient insulin...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics